<DOC>
	<DOCNO>NCT00418470</DOCNO>
	<brief_summary>Patients cystic fibrosis ( CF ) need frequently undergo course IV antibiotic therapy . To avoid high number venipuncture peripheral venous catheter ( SPVC ) cannula use . Because irritant action drug use , SPVC 's often last whole antibiotic course ( usually two week ) patient puncture insertion new IV line . With passing time vein difficult find . An alternative use cannula surgical insertion central venous catheter . This intervention may contraindications , specially adolescent , cause unacceptable alteration body image . The aim study find way prolong duration SPVC use CF patient antibiotic course avoid irritation vein phlebitis . Design study : randomize controlled trial . The study see collaboration nurse , physician technician Tuscan CF Centre . The patient participate study randomly assign one two group : one group receive antibiotic prescribe accord maximal dilution suggest pharmaceutical company , receive much high dilution ( i.e . high volume Normal Saline ) , time administration . The assessment regard : level inflammation vein ( special visual scale ) duration SPVC . The hypothesis prove dilute antibiotic high volume Normal Saline possible delay prevent irritation vein onset phlebitis . In case hypothesis confirm study easy , secure , low cost immediately available system available reduce number venipuncture necessary complete course IV antibiotic .</brief_summary>
	<brief_title>Prolonging Duration Peripheral Venous Catheters Cystic Fibrosis People</brief_title>
	<detailed_description>Background Cystic Fibrosis ( CF ) common genetic disease affect , among organ , respiratory tree . The major cause mortality morbidity CF pulmonary infection cause limited number bacteria , particular gram negative bacteria Pseudomonas aeruginosa ( PA ) Burkholderia cepacia complex ( BCC ) cause frequent clinically acute pulmonary infection . Current figure show 57.3 % patient lung infect PA 2.9 % lung infect BCC ( 1 ) . To fight pulmonary exacerbation , patient frequently undergo antibiotic treatment , often give orally aerosol administer intravenously ( IV ) . Some CF Centers also adopt treatment protocol patient chronically infected respiratory pathogen prophylactic IV course antibiotic routinely give every 3 month even absence clinical symptom pulmonary exacerbation ( 2 ) An IV course antibiotic treatment continue least 10 day usually last 2 week ( 3 ) . Completing would therefore require numerous venipuncture patient . In USA , 2004 45 % patient age 18 30 require least 1 IV antibiotic course , 25 % 2 IKV course 15 % 3 course ( 1 ) . This IV treatment regime bring relevant burden pain , anxiety worsen quality life ( 4 ) . In order reduce number venipuncture need antibiotic course , several intravenous indwell device use administer antibiotic infusion . Some venous catheter inserted central vessel . Among , port caths Groshong Broviac type Central catheter , Midline catheter commonly use ( 5-9 ) . They intend last several week year . Their insertion require surgical intervention . Such invasive intervention may sometimes indicate due patient 's clinical condition . Moreover , presence permanent device may influence patient ' body image autonomy , negative consequence psychological condition patient , especially adolescence ( 10 ) . Also , systemic infection may occur ( 11 ) , permanent management device may result complicate ( 12-15 ) may influence patient 's day-to-day life . Recently , high incidence thrombosis relate insertion kind catheter describe ( 16 ) The commonly use type IV device administer antibiotic CF short peripheral venous catheter ( SPVC ) cannula ( 17 , 18 ) consider long simple , easy-to-use economic way administer IV therapy CF . The use device allow patient puncture every administration eventually perform antibiotic course home avoid hospitalisation therefore maintain relatively normal daily life . Moreover , compare previously describe permanent device , one less invasive , require surgical intervention insert , intend maintain duration treatment . In order facilitate CF people 's autonomy reduce condition quality life , The home administration IV antibiotic become increasingly common ( 17-21 ) . In 2004 , 20.1 % US CF patient receive home IV treatment ( 1 ) . Patients relatives often trained CF Centers ' Nurses manage administration antibiotic treatment . Typical responsibility CF Center 's Nursing Staff position SPVC , manage venous access drug infusion , evaluate site cannula insertion drug administration , educate patient possible complication ( 21-23 ) . During course , patency venous access one antibiotic administration follow achieve flush catheter end infusion either normal saline heparin solution . With passing time , SPVC insertion might become increasingly difficult due repeat venous trauma , may lead formation thrombus progressive occlusion vein ; ( 17 ) . Due particular respiratory pathogen ( PA , BCC ) affect CF patient ' lung dose antibiotic much high administer non-CF patient pneumonia . Even though sensibly lower risk infectious problem , IV administration high dos antibiotic , may irritate vein ' tunica intima cause phlebitis may occlude vein therefore interrupt vein 's patency . Indeed , well establish infusion antibiotic irritant substance frequently cause iatrogenic phlebitis ( 24-28 ) . Other factor discuss risk factor onset phlebitis short duration SPVC ( 29 ) ; among others , movement patient , his/her age , type SPVC , type dressing use , site insertion ( 30 ) blood count , ( 25 ) . The onset phlebitis oblige healthcare provider reposition venous catheter another site cause patient suffering , pain anxiety . Although scarcely investigate , problem reduce amount venipuncture pain CF patient clinically important . A recent study research group examine recall adult CF patient invasive procedure receive childhood ( 31 ) . The study evidence repeat venipuncture imply additional worsening quality life may influence CF child future compliance treatment . So far study investigate effective way prolong duration SPVCs use without cause phlebitis , substantially inconclusive ( 32,33 ) On basis exist study , hypothesise volume fluid antibiotic dilute , consequently concentration , may affect vein ' tunica intima irritation . Specific Aims Rationale This study aim investigate whether different concentration prescribe dose antibiotic infusate intravenous administration influence inflammation vessel consequent duration SPVCs patient CF undergo antibiotic course . For antibiotic administer IV , producer , besides type infusate , provide also suggest maximum concentration concentration range . Theoretically possible reduce vessel 's irritation keep quantity drug time infusion constant , dilute prescribed amount antibiotic large volume infusate , give interval time . This would lead small number drug molecule act irritant tunica intima . Therefore , aim study verify hypothesis great volume infusate constant amount drug dose time , reduces irritation vessel 's tunica intima cause antibiotic allows longer patency vein longer use SPVC . We compare outcomes two different concentration antibiotic Normal Saline , mostly use infusate IV administration antibiotic . The type prescribe antibiotic time infusion stay . The CF center specialist physician continue prescribe drug usual , accord intern protocols patient ' clinical condition . The eventual purpose study reduce patient ' distress discomfort oblige undergo antibiotic treatment need invasive procedure . Indeed , test hypothesis would confirm , simply increase volume normal saline antibiotic dilute would lead less vein irritation , low incidence phlebitis long permanence SPVC use IV antibiotic course . This would imply reduction number venepunctures need complete IV antibiotic course reduction patient discomfort pain . Also , test hypothesis would confirm , solution propose would immediately applicable clinical practice , since would require authorization process . Also , would little expense completely safe , unless contraindication exist infusion high volume Normal Saline Besides , CF Centers ' Health Care Providers might simple , safe relatively low-cost method prolong duration site IV antibiotic course reduce number venepunctures give patient . Preliminary result Recently group researcher carry observational study , partially retrospective partially prospective ( 34-36 ) . We study 87 SPVCs insert 36 patient 56 IV antibiotic treatment cycle period 6 month ( mean duration 8.3 day ) . It evidence gauge SPVC number daily administration significantly correlate duration site cannula . In particular , SPVCs large gauge ( G22 ) longer mean duration small ( G24 ) SPVCs ( 9.6 day vs. 7.2 day , p=0.03 ) SPVCs use antibiotic course antibiotic daily dose divide 3 administration longer mean duration ( 10.3 day ) use course daily dose divide 2 administration ( 6.5 day , p=0.001 ) . According study , factor patient ' age , brand cannula , health care professional insert cannula , site insertion ( dominate non dominate arm ) , concurrent administration oral anti-inflammatory drug seem influence duration SPVC site . The result study lead researcher hypothesise concentration antibiotic infusion i.e . dilution might impact local inflammation vessel . Indeed , since single administration administer infusion volume 100 ml , patient receive daily antibiotic dose divide 3 administration receive daily antibiotic dose dilute high volume fluid daily administration . The study group compose Nurses , Physician Technician long experience CF research . The group carry also study aim find way cure receive patient least impact possible quality life . In particular study group 's interest focus issue pain CF patient ( 31 , 37 , 38 ) . Experimental Plan Study design : Randomized control non-blinded clinical trial . The study confront effect two different antibiotic concentration administer IV inflammation vein duration situ insert SPVC . The assignment patient one group do randomization . Randomization launch researcher blind regard patient . Data analysis do researcher blind regard patient . The study influence usual course therapeutic treatment choose specialized physician CF center . The experimental variable concentration dose antibiotic prescribed physician infusate , volume fluid need infuse antibiotic . In aim reduce number possible confounding variable , age range patient , SPVC gauge brand , type dressing , scale use evaluation irritation infiltration , type antibiotic use , time infusion , number attempt SPVC insertion standardize . Authorization Ethic Committee Meyer Children Hospital obtain . Subjects include study sign inform consent consent treat personal data . They receive write information study . Data analyze present aggregated form mean possible retrace subject data refer . Subjects , Materials Methods This multidisciplinary study participation Nurse researcher , Physician researcher They participate study accord field professional competence legal responsibility describe law force Italy . In particular , Physicians make diagnosis order prescription nurse administer therapy , choose use appropriate IV device accord clinical condition patient , notice assess sign symptom use validated scale , educate instruct patient therapy . Patients recruitment study do Physician Nurse together assess fulfilment inclusion criterion inform patient . The Nurses participate study possess qualification practise profession graduate degree Nursing equivalent instruct principal investigator regard use assessment scale use study , participant ' inclusion criterion research protocol . Inclusion criterion To include study subject need fulfil follow requirement : - diagnosis cystic fibrosis , make accordingly Cystic Fibrosis Foundation Guideline ( Rosenstein BJ . J Pediatr 1998 ; 132 : 589-595 ) - age 18 year ability consciously express own informed consent . - prescription do one CF Centre specialist Physicians IV antibiotic course foreseen duration 2 week , due pulmonary exacerbation , association ceftazidime 3 time daily tobramycin daily dilute Normal Saline . - absence clinical condition contraindicate administration 350ml Normal Saline 30 minute 3 time daily 400ml Normal Saline 40 minute . - simultaneous anti-inflammatory therapy administer orally , IM IV - 30 day pass end previous course . - IV course give subject inpatient , admit hospital The two experimental group follow treatment : Group A : Ceftazidime infuse dilute Normal Saline maximum suggest concentration 40mg per ml infusate . Time infusion : 30 minute . Group B : Ceftazidime infuse dilute Normal Saline concentration 10mg per ml infusate . Time infusion : 30 minute . For group Tobramycin infuse dilute Normal Saline concentration 1mg per ml infusate ( i.e. , one half maximum suggest concentration 1mg per ml infusate ) . Time infusion : 40 minute . Measured outcome : - irritation level first vein cannulated course . The assessment do utilize `` Phlebitis Scale '' Standard Practice Intravenous Nurses Society ( 39 ) . The Scale describe `` Clinical Protocol '' Section.. - number day first SPVC use treatment course stay situ removal . For two group calculation do : The proportion subject score 0 1 `` Phlebitis Scale '' single day observation ( 1st day , 2nd dayâ€¦ 14th ) The mean duration first SPVC inserted treatment course Statistical Analysis Differences proportion analyse Chi-square test . Differences mean situ duration SPVCs analyse use Student t-test . Statistical significance level establish 95 % . The removal first SPVC insert antibiotic course conclude participation subject study . The SPVC remove follow case : - At end IV course - If phlebitis level 2 `` Phlebitis Scale '' - If infiltration level 1 `` Infiltration Scale '' Standard Practice Intravenous Nurses Society ( 39 ) . The Scale describe `` Clinical Protocol '' Section . - If pain rat 3 numeric pain scale 0 10 ( 40 ) . If subject need prolong antibiotic therapy 14 day participation subject study 14th day . The subject readmitted study 30 day pass end previous course . The subject drop-out - He ask remove SPVC take away autonomously decide refuse therapy . - The patient start contraindication volume Normal Saline infuse - The patient start take anti-inflammatory drug orally IM IV . - Patient refuse prescribed therapy 3 administration 2 consecutive administration . - One prescribed antibiotic modify specialized physician CF Centre change clinical condition subject ; modification dose ceftazidime tobramycin interrupt participation study concentration infusate remain . If case volume Normal Saline change accord new dose subscribe . - The SPVC use take blood sample injection drug ceftazidime tobramycin . - The prescribed concentration respect , even happen one time . The data level inflammation vein take moment drop include analysis accord intention treat . The duration SPVC take account . Determining sample numerosity The CF Center Tuscany take care 191 patient . 78 patient ( 41 % ) adult potentially recruitable study . All patient Tuscan Regional CF Center see Outpatients clinic regularly evaluate clinical status microbiology respiratory tract secretion . According data find preliminary study do group research ( 34 ) , antibiotic course match inclusion criterion study one year 50 Tuscan CF Centre Florence . To determine numerosity sample t-test difference mean SPVC duration , fix power trial 0.8 . In absence reference measure , hypothesise minimum expect difference SPVC duration two experimental group equal find preliminary study carry research group ( 34 ) patient give IV antibiotic 2 time day receive 3 time day , , 3.8 day . Also , hypothesize standard deviation within group equal find two group preliminary study , , 5 . On basis expect value , numerosity two experimental group determine 30 group . Such number increase number subject equal number drop-outs . Randomization A simple randomization method utilized . One participant research group randomization role study . He blind concern patient know neither identity clinical status . Every time patient recruit study researcher , Physician Nurse do recruitment contact researcher responsible randomization communicate new patient include without give information patient . The person responsible randomization flip 50 cent Euro coin air communicate result . The recto coin ( one indicate coin value ) mean inclusion Group A . The verso coin ( one national insign ) mean inclusion Group B . The person responsible randomization reachable telephone dedicate mobile phone CF Center opening time . The study end group reach numerosity establish priori , plus number drop-outs . Sequence Timetable Project January 2007 : education Nurses Physicians work clinical aspect study ( recruitment , cannulation , know research protocol preparation expect concentration ; assessment cannulation site use scale , education patient ) ; February 2007 : begin recruitment patient start study June 2007 : first check recruit patient quality collect data October 2007 : second check recruit patient quality collect data Retraining person collaborate study Principal investigator . February 2008 : third check recruit patient quality collect data June 2008 : fourth check recruit patient quality collect data Retraining person collaborate study Principal investigator . October 2008 : fifth check recruit patient quality collect data February 2009 : 6th check recruit patient quality collect data Retraining person collaborate study Principal investigator . June 2009 : 7th check recruit patient quality collect data November 2009 : end data collection . Insertion paper data Microsoft Access 2000 database . December 2009 . Statistical analysis . Writing final report . Paper send evaluation peer-reviewed scientific journal Clinical protocol Recruitment patient In occasion patient 's visit CF Center Outpatient Clinic , Physician decide , basis clinical condition patient , laboratory test , result sputum culture instrumental imaging diagnostic test , whether need antibiotic treatment , type way administration . If physician decides prescribe antibiotic , inclusion criterion verify . If criterion satisfy , subject eligible inclusion study . The patient invite participate study give necessary information . After answer his/her question , patient accepts inclusion , Physician Nurse collect his/her write informed consent . Subsequently Nurse call researcher charge randomisation ask group patient assign . Subsequently , Nurse collect initial data patient recruitment form . Then insert SPVC . Way administration treatment To administer treatment Gauge 22 SPVCs Intima BD use . Before insertion SPVC use local anaesthetic cream propose patient , clinically contraindicate . Before insertion , insertion site disinfect Amukine 5 % solution . Skin hair remove . After insertion SPVC fix skin sterile transparent dressing . The dress change take away experimentation order avoid displacement cannula . The SPVC close needleless lock cap assessed subject . Each infusion administer total 70 minute : 30 minute ceftazidime 40 minute tobramycin . There flush first second antibiotic . At end infusion , cannula flush 1.5 ml heparin solution ( 25 U/ml Normal Saline ) . During experimentation SPVC use therapy take blood sample . Preparation concentration research protocol : Table 1 indicate dilution prepare single administration ceftazidime , accord prescribe dose Group A - 2000 mg ... . 50 ml - 2500 mg ... . 62,5 ml - 3000 mg ... . 75 ml Group B - 2000 mg ... . 200 ml - 2500 mg ... . 250 ml - 3000 mg ... . 300 ml Table 2 show dilution prepare every single administration tobramycin , accord prescribe dose . Both group - 150 mg ... . 75 ml - 200 mg ... . 100 ml - 250 mg ... . 125 ml - 300 mg ... . 150 ml - 350 mg ... . 175 ml - 400 mg ... . 200 ml In order facilitate preparation antibiotic infuse accord concentration show research protocol , pharmaceutical company prepare Normal Saline bottle prefilled volume need study . Clinical assessment At moment recruitment study follow data collect : Age sex , FEV1 ( percentage predict ) , body mass index , PCR , microorganism sputum culture , number attempt need insert SPVC . Every day , IV midday administration researcher ass : 1 . The state irritation vein SPVC insert , use `` Phlebitis scale '' Standard Practice Intravenous Nurses Society ( 39 ) , follow Grade Clinical Criteria - Grade 0 ... . No symptoms - Grade 1 ... . Erythema access site without pain - Grade 2 ... . Pain access site erythema and/or edema - Grade 3 ... . Pain access site erythema and/or edema . Streak formation . Palpable venous cord - Grade 4 ... . Pain access site erythema and/or edema . Streak formation . Palpable venous cord &gt; 1 inch length . Purulent drainage 2 . The state infiltration vein SPVC insert , use `` Infiltration scale '' Standard Practice Intravenous Nurses Society ( 39 ) As follow . - Grade 0 ... . No symptoms - Grade 1 ... . Skin blanch , edema &lt; 1 inch direction , cool touch , without pain - Grade 2 ... . Skin blanch , edema 1-6 inch direction ; cool touch ; without pain . - Grade 3 ... . Skin blanch , translucent ; gross edema &gt; 6 inch direction ; cool touch ; mild-moderate pain ; possible numbness . - Grade 4 ... . Skin blanch , translucent ; skin tight , leaking , skin discolour , bruise , swell ; gross edema &gt; 6 inch direction ; deep pitting tissue edema ; circulatory impairment ; moderate-severe pain ; infiltration amount blood product , irritant , vesicant 3 . The pain experience locally patient use numeric pain scale . 4 . Adverse event , physical activity perform event relate antibiotic course may occur previous 24 hour , describe patient . The researcher ascertain , question check , previous 24 hour dilution provide research protocol respect violation protocol occur . In rare case , patient start course inpatient may continue home , describe ( 23 ) . In case patient give high resolution mobile videophone . The researcher phone patient , interview ass insertion site use videophone . The validity kind distance evaluation recently show study perform leg ulcer ( 41 ) . If assessor score insertion site 2 `` Phlebitis Scale '' , 1 `` Infiltration scale '' , patient report local pain 3 pain numeric rating scale , SPVC remove observation subject study end . Quality control Every 4 month Principal Investigator verify number recruit patient quality collect data , analyse daily assessment form . In case drop-outs number patient recruit increased equal number subject . Every 8 month Principal Investigator retrain collaborator involve study particular regard : recruiting , vein cannulation , knowledge research protocol , preparation antibiotic dilution , use scale , train patient . Safety For research use method drug deviate normal clinical practice ; apply usual operational procedure prevention Clinical Risk approve Hospital Local Committee Patient Safety Clinical Risk Management , provide Tuscan Regional Government Decree n. 1387/2004 ) . Also , Principal Investigator member Committee . Adverse event relate participation study constantly monitor . A member study group always reachable phone patient problem may occur study . Data management statistical analysis Data store Microsoft Access 2000 database . Statistical analysis perform independent free-lance Statistician , belong Researchers ' Institution .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Phlebitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Diagnosis cystic fibrosis , make accordingly Cystic Fibrosis Foundation Guideline ( Rosenstein BJ . J Pediatr 1998 ; 132 : 589595 ) age 18 year ability consciously express own informed consent . prescription do one CF Centre specialist Physicians IV antibiotic course expect duration 2 week , due pulmonary exacerbation , association ceftazidime 3 time daily tobramycin daily dilute Normal Saline . absence clinical condition contraindicate administration 350ml Normal Saline 30 minute 3 time daily 400ml Normal Saline 40 minute . simultaneous antiinflammatory therapy administer orally , IM IV 30 day pass end previous course . The IV course give subject inpatient , admit hospital</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>Catheterization , peripheral</keyword>
	<keyword>Phlebitis</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
	<keyword>Osmolar Concentration</keyword>
</DOC>